Tensions rise as AstraZeneca, EU spar over vaccine delays

first_imgBRUSSELS (AP) — The European Union and drugmaker AstraZeneca sparred Wednesday over a delay in coronavirus vaccine deliveries as the deepening dispute raises concerns about the increasing competition for limited supplies of shots needed to end the pandemic. AstraZeneca Chief Executive Pascal Soriot addressed the dispute for the first time, rejecting the EU’s assertion that the company was failing to honor its commitments. Soriot said vaccine delivery figures in AstraZeneca’s contract with the 27-nation bloc were targets, not firm commitments, and they couldn’t be met because of problems in rapidly expanding production capacity.last_img